Related Experiment Video
Updated: Dec 9, 2025

06:31
Studying Surfactant Effects on Hydrate Crystallization at Oil-Water Interfaces Using a Low-Cost Integrated Modular Peltier Device
Published on: March 18, 2020
6.7K
Ethoxylated copolymersurfactants for the HFA134a- interface: interfacial activity, aggregate microstructure and
Parthiban Selvam1, Udayan Chokshi1, Ayanna Gouch1
1Department of Chemical Engineering and Materials Science, Wayne State University, 5050 Anthony Wayne Dr., Detroit, MI 48202, USA. sdr@eng.wayne.edu.
Soft Matter
|September 10, 2020
Summary
Ethoxylated copolymer surfactants form reverse aggregates in 1,1,1,2-tetrafluoroethane (HFA134a) and water, capable of encapsulating biomolecules for potential drug delivery applications.
Area of Science:
- Colloid and Surface Chemistry
- Materials Science
- Biophysical Chemistry
Background:
- Ethoxylated copolymer surfactants exhibit unique interfacial behavior in fluorinated propellants.
- Understanding aggregate formation is crucial for developing novel drug delivery systems.
Purpose of the Study:
- To investigate the aggregation behavior of ethoxylated copolymer surfactants in 1,1,1,2-tetrafluoroethane (HFA134a) and water.
- To determine the capacity of these aggregates to uptake model biomolecules.
Main Methods:
- In situ high-pressure tensiometry to determine interfacial properties.
- UV-vis spectroscopy to assess water solubilization capacity.
- Small-angle neutron scattering (SANS) to investigate aggregate microstructure and biomolecule uptake.
Main Results:
- The optimal hydrophilic-to-HFA-philic balance (HFB) for EO3PO43EO3 surfactants at the HFA134a|W interface was identified.
- Spectroscopic data confirmed water solubilization within surfactant aggregates.
- SANS confirmed the uptake of a model protein within reverse aggregates.
Conclusions:
- Ethoxylated copolymer surfactants can form reverse aggregates in HFA134a capable of encapsulating hydrophilic biomolecules.
- These reverse aggregates show promise as formulations for lung delivery of drugs and biomolecules.

